HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.

Abstract
In the extension areas of the Onchocerciasis Control Programme in West Africa, aerial larviciding is supplemented with annual ivermectin treatment, mainly to achieve better control of morbidity. The purpose of this study is to determine whether and to what extent the addition of annual ivermectin treatment permits earlier cessation of vector control than originally recommended. The effectiveness of combined ivermectin distribution and vector control was assessed using an epidemiological model. Model predictions suggest that, dependent on the pre-control endemicity of the area and the proportion of persons treated during each ivermectin round, large-scale annual treatment permits a considerable reduction in the duration of vector control. Taking into account uncertainty about the efficacy of ivermectin, our results indicate that, provided treatment coverage is at least 65% and there is no importation of infection from elsewhere, 12 years of combined control will be sufficient to reduce the risk of recrudescence to below 1% in even the most afflicted areas.
AuthorsA P Plaisier, E S Alley, G J van Oortmarssen, B A Boatin, J D Habbema
JournalBulletin of the World Health Organization (Bull World Health Organ) Vol. 75 Issue 3 Pg. 237-45 ( 1997) ISSN: 0042-9686 [Print] Switzerland
PMID9277011 (Publication Type: Journal Article)
Chemical References
  • Antinematodal Agents
  • Filaricides
  • Ivermectin
Topics
  • Adolescent
  • Adult
  • Animals
  • Antinematodal Agents
  • Burkina Faso (epidemiology)
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Female
  • Filaricides (therapeutic use)
  • Humans
  • Infant
  • Insect Control (methods)
  • Ivermectin (therapeutic use)
  • Male
  • Middle Aged
  • Models, Statistical
  • Onchocerciasis (epidemiology, prevention & control)
  • Population Surveillance
  • Prevalence
  • Program Evaluation
  • Simuliidae
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: